Patients on Bisphosphonates: Current Thoughts on Implant Treatment?
Last Updated: Jun 16, 2011
Dr. T asks:
There is universal agreement that high dose intravenous bisphosphonates for e.g. myeloma or disseminated carcinoma, are an absolute contraindication to dental implants, whereas most US implantologists do not seem overly worried about treating clients on low dose oral bisphosphonates, such as Fosamax 70mg weekly.
However, I am seeing more and more patients who are on monthly, 3-monthly or annual regimes and I would be interested in your views on the wisdom of treating these people with dental implants. None of the various position papers on oral surgery and bisphosphonates seem to tackle these “in between” cases. Any comments?
9 Comments on Patients on Bisphosphonates: Current Thoughts on Implant Treatment?
Tyler
06/19/2011
Dr C
06/19/2011
Dr. Wolanski
06/21/2011
Dr. B
06/23/2011
Dr. Wolanski
06/27/2011
Dr. Wolanski
06/27/2011
Dr.B
06/27/2011
Dr. Godinho
02/22/2012
Featured Products
Classic 50/50 Mix
Promotes osteoconduction
Provides structural integrity
Convenient Syringe!
50/50 Cortical/Cancellous
Available in 3 sizes.
Eliminate hassle of mixing particulate grafts
Sold in packs of 5 or packs of 10.
Proven safe, and clinically effective
Resorbable collagen membrane derived from purified porcine pericardium
Fast hydration and excellent tensile strength
Good adaptation to various defects
Excellent tear function and duration
100% allograft
Eliminates mixing hassle
Moldable after hydration
Dr. C
06/16/2011